Document is current
Any future updates will be listed below
-
Authors
Ri, Masaki
Iida, Shinsuke
Saito, Kosuke
Saito, Yoshiro
Maruyama, Dai
Asano, Arisa
Fukuhara, Suguru
Tsujimura, Hideki
Miyazaki, Kana
Ota, Shuichi
Fukuhara, Noriko
Negoro, Eiju
Kuroda, Junya
Yoshida, Shinichiro
Ohtsuka, Eiichi
Norifumi, Tsukamoto
Tabayashi, Takayuki
Takayama, Nobuyuki
Saito, Toko
Suzuki, Yasuhiro
Harada, Yasuhiko
Mizuno, Ishikazu
Yoshida, Isao
Maruta, Masaki
Takamatsu, Yasushi
Katsuya, Hiroo
Yoshimitsu, Makoto
Minami, Yosuke
Kanato, Keisuke
Munakata, Wataru
Nagai, Hirokazu
-
Funding
Funding for this research was provided by:
National Cancer Center Research and Development Fund ((26-A-4, 29-A-3, 2020-J-3, 2023-J-03))
Accelerating Regulatory Science Initiative from the Ministry of Health, Labour and Welfare
Grant-in-Aid for Clinical Cancer Research from the Ministry of Health, Labour and Welfare of Japan ((H26-kakushin-teki-gan-ippan-074))
Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development, AMED (JP16ck0106077 and JP19ck0106348.)
- License Information
-
More Information
Article History
Received: 21 December 2024
Accepted: 13 January 2025
First Online: 24 January 2025
Declarations
:
: The authors declare no competing interests.
: S.I., J. K., N. T., H. N., K. M., and M. R. report honoraria from Janssen Pharmaceutical. S.I., J. K., H. N., and M. R. report research funding from Janssen Pharmaceutical. The other authors report no conflicts of interest.
